Publications by authors named "Kevin W Harris"

Claim this Profile
L
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Madison R Chandler, Kimberly S Keene, Johanna M Tuomela, Andres Forero-Torres, Renee Desmond, Kevin W Harris

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.
Jouko Sandholm, Jaakko Lehtimäki, Tamiko Ishizu, Sadanandan E Velu, Jeremy Clark, Kevin W Harris

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.
Johanna M Tuomela, Jouko A Sandholm, Mika Kaakinen, Katherine L Hayden, Kirsi-Maria Haapasaari, Kevin W Harris

Breast Cancer Res Treat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro.
Jouko Sandholm, Johanna Tuomela, Joonas H Kauppila, Kevin W Harris, David Graves

Oncol Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells.
Johanna Tuomela, Jouko Sandholm, Mika Kaakinen, Ankita Patel, Joonas H Kauppila, Kevin W Harris

Breast Cancer Res Treat· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer.
Johanna Tuomela, Jouko Sandholm, Joonas H Kauppila, Petri Lehenkari, Kevin W Harris

Oncol Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
Johanna Tuomela, Jouko Sandholm, Peeter Karihtala, Joanna Ilvesaro, Katri S Vuopala, Kevin W Harris

Breast Cancer Res Treat· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.
Jouko Sandholm, Joonas H Kauppila, Christine Pressey, Johanna Tuomela, Arja Jukkola-Vuorinen, Kevin W Harris

Breast Cancer Res Treat· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia.
Heidi J Nick, Hyung-Gyoon Kim, Chia-Wei Chang, Kevin W Harris, Vishnu Reddy

Blood· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.
Arja Jukkola-Vuorinen, Eeva Rahko, Katri S Vuopala, Renee Desmond, Petri P Lehenkari, Kevin W Harris

J Innate Immun· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
Savita Wakchoure, Telisha Millender Swain, Teuvo A Hentunen, Asne R Bauskin, David A Brown, Kevin W Harris

Prostate· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Joanna M Ilvesaro, Melinda A Merrell, Li Li, Savita Wakchoure, David Graves, Kevin W Harris

Mol Cancer Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
Melinda A Merrell, Savita Wakchoure, Petri P Lehenkari, Kevin W Harris, Katri S Selander

Eur J Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
Joanna M Ilvesaro, Melinda A Merrell, Telisha Millender Swain, Jennifer Davidson, Majd Zayzafoon, Kevin W Harris

Prostate· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells.
Melinda A Merrell, Savita Wakchoure, Joanna M Ilvesaro, Kurt Zinn, Bradley Gehrs, Kevin W Harris

Eur J Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An essential role for gp130 in neointima formation following arterial injury.
Dong Wang, Zhimin Liu, Quanyi Li, Manjula Karpurapu, Venkatesh Kundumani-Sridharan, Kevin W Harris

Circ Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Melinda A Merrell, Joanna M Ilvesaro, Niko Lehtonen, Timo Sorsa, Bradley Gehrs, Kevin W Harris

Mol Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.
Savita Wakchoure, Melinda A Merrell, Wayne Aldrich, Telisha Millender-Swain, Kevin W Harris

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
Catalina Suarez-Cuervo, Melinda A Merrell, Latania Watson, Kevin W Harris, Eben L Rosenthal

Clin Exp Metastasis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Katri S Selander, Li Li, Latania Watson, Melinda Merrell, Heike Dahmen, Kevin W Harris

Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition.
Melinda Merrell, Catalina Suarez-Cuervo, Kevin W Harris, H Kalervo Väänänen, Katri S Selander

Breast Cancer Res Treat· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells.
Catalina Suarez-Cuervo, Kevin W Harris, Lisa Kallman, H Kalervo Väänänen, Katri S Selander

Breast Cancer Res Treat· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis.
Suzanne Burns, Murat O Arcasoy, Li Li, Elizabeth Kurian, Katri Selander, Kevin W Harris

Blood· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis